Goniothalamin(CAS: 17303-67-2)

Goniothalamin (CAS: 17303-67-2) is regulated under the Globally Harmonized System (GHS) of Classification and Labelling of Chemicals, which classifies it as a skin irritant. It is also subject to the European Union’s Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulation. In the United States, it is regulated by the Environmental Protection Agency (EPA) and the FDA for specific applications, such as in cosmetics. Always ensure compliance with local and national regulations.

For synthesis purposes, alternatives to Goniothalamin (CAS: 17303-67-2) include similar triterpenoids like ursolic acid and oleanolic acid. These compounds can serve as effective substitutes due to their similar chemical properties and biological activities. Using these alternatives can help optimize the synthesis process and reduce costs.

The market for Goniothalamin (CAS: 17303-67-2) is growing due to its potential medicinal properties, particularly in cancer research. Research trends focus on its anti-inflammatory and anticancer activities. The compound is also being explored for its role in treating cardiovascular diseases. Market demand is expected to increase as more studies confirm its therapeutic potential.

Waste containing Goniothalamin (CAS: 17303-67-2) should be carefully managed to prevent environmental contamination. Collect waste liquids in appropriate containers and seal them tightly. For disposal, incineration is a common method, but professional waste disposal services should be used to ensure safety and compliance. Proper environmental protection measures, such as containment and neutralization if necessary, should be followed.